FI48922C - Process for the preparation of pharmaceutically active novel, both racemic and optically active substituted 1-phenoxy-2-hydroxy-3-tert-butyl aminopropanes and these salts. - Google Patents

Process for the preparation of pharmaceutically active novel, both racemic and optically active substituted 1-phenoxy-2-hydroxy-3-tert-butyl aminopropanes and these salts.

Info

Publication number
FI48922C
FI48922C FI681664A FI166468A FI48922C FI 48922 C FI48922 C FI 48922C FI 681664 A FI681664 A FI 681664A FI 166468 A FI166468 A FI 166468A FI 48922 C FI48922 C FI 48922C
Authority
FI
Finland
Prior art keywords
aminopropanes
racemic
phenoxy
tert
hydroxy
Prior art date
Application number
FI681664A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI48922B (en
Inventor
Herbert Koeppe
Karl Zeile
Albrecht Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of FI48922B publication Critical patent/FI48922B/fi
Publication of FI48922C publication Critical patent/FI48922C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI681664A 1967-06-15 1968-06-14 Process for the preparation of pharmaceutically active novel, both racemic and optically active substituted 1-phenoxy-2-hydroxy-3-tert-butyl aminopropanes and these salts. FI48922C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967B0093025 DE1593782B2 (en) 1967-06-15 1967-06-15 1-NITRILOPHENOXY- 2- HYDROXY -3- TERT.BUTYLAMINOPROPANE, THE PROCESS FOR THEIR MANUFACTURING AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THESE

Publications (2)

Publication Number Publication Date
FI48922B FI48922B (en) 1974-10-31
FI48922C true FI48922C (en) 1975-02-10

Family

ID=6986720

Family Applications (1)

Application Number Title Priority Date Filing Date
FI681664A FI48922C (en) 1967-06-15 1968-06-14 Process for the preparation of pharmaceutically active novel, both racemic and optically active substituted 1-phenoxy-2-hydroxy-3-tert-butyl aminopropanes and these salts.

Country Status (17)

Country Link
JP (2) JPS51100B1 (en)
AT (8) AT289067B (en)
BE (1) BE716647A (en)
BG (6) BG15039A3 (en)
CH (1) CH495950A (en)
DE (1) DE1593782B2 (en)
DK (1) DK127059B (en)
ES (6) ES354823A1 (en)
FI (1) FI48922C (en)
FR (2) FR1583559A (en)
GB (1) GB1187546A (en)
IE (1) IE32373B1 (en)
IL (1) IL30181A (en)
MY (1) MY7300288A (en)
NL (2) NL6808196A (en)
SE (1) SE355571B (en)
YU (7) YU33777B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
JPS57125772U (en) * 1981-01-30 1982-08-05
DE3744371A1 (en) * 1987-12-29 1989-07-13 Jacobs Suchard Ag PACKAGING FOR CONFECTIONERY
DE4014252A1 (en) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed (-)-1-(4'-Amino-3'-cyanophenyl)-2-iso-propyl-amino-ethanol - for treating fatty degeneration, obstructive lung disorders, allergic bronchial asthma, spastic bronchitis and premature labour

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (en) * 1962-12-11

Also Published As

Publication number Publication date
YU33780B (en) 1978-05-15
AT289079B (en) 1971-04-13
ES368399A1 (en) 1971-05-01
YU33777B (en) 1978-05-15
DE1593782B2 (en) 1976-09-09
DK127059B (en) 1973-09-17
YU229474A (en) 1977-10-31
IE32373L (en) 1968-12-15
AT289077B (en) 1971-04-13
YU229074A (en) 1977-10-31
AT289080B (en) 1971-04-13
IE32373B1 (en) 1973-07-11
YU33778B (en) 1978-05-15
AT289081B (en) 1971-04-13
JPS5112613B1 (en) 1976-04-21
ES368401A1 (en) 1971-05-01
ES368398A1 (en) 1971-05-01
AT289082B (en) 1971-04-13
YU35578B (en) 1981-04-30
MY7300288A (en) 1973-12-31
YU33779B (en) 1978-05-15
NL136601C (en)
ES354823A1 (en) 1970-02-16
BG15039A3 (en) 1975-12-15
AT289067B (en) 1971-04-13
BG15041A3 (en) 1975-10-22
BE716647A (en) 1968-12-16
YU33776B (en) 1978-05-15
FR8162M (en) 1970-08-24
CH495950A (en) 1970-09-15
ES368396A1 (en) 1971-05-01
BG15040A3 (en) 1975-10-25
BG15038A3 (en) 1975-06-10
BG15037A3 (en) 1975-12-12
DE1593782A1 (en) 1972-04-20
NL6808196A (en) 1968-12-16
IL30181A (en) 1972-01-27
JPS51100B1 (en) 1976-01-05
YU229174A (en) 1977-10-31
FR1583559A (en) 1969-11-14
YU228874A (en) 1977-10-31
GB1187546A (en) 1970-04-08
AT289076B (en) 1971-04-13
AT289078B (en) 1971-04-13
SE355571B (en) 1973-04-30
YU229274A (en) 1977-10-31
YU229374A (en) 1980-09-25
IL30181A0 (en) 1968-08-22
YU33775B (en) 1978-05-15
ES368395A1 (en) 1971-05-01
YU228974A (en) 1977-10-31
FI48922B (en) 1974-10-31
BG15042A3 (en) 1975-10-20

Similar Documents

Publication Publication Date Title
FI48460C (en) Process for the preparation of pharmacologically active novel amino-dihalophenylethylamines.
FI49300C (en) Process for the preparation of therapeutically active 1,4-dihydropyridine derivatives.
DK131029B (en) Analogous process for the preparation of racemic or optically active 1-phenoxy-2-hydroxy-3-alkylaminopropanes or acid addition salts thereof.
DK129447B (en) Analogous process for the preparation of racemic or optically active 1-phenoxy-2-hydroxy-3-sec-alkylaminopropanes or acid addition salts thereof.
FI48189C (en) Process for the preparation of novel racemic or optically active, therapeutically active norwegian polyamine derivatives
ES393914A0 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF PHENYLACETIC ACID, RACEMIC, OR OPTICALLY ACTIVE
FI50969C (en) Process for the preparation of novel, tricyclically substituted 1-naphthoxy-2-hydroxy-3-ethylaminopropanes and salts thereof having an effect on cardiac function and blood circulation.
FI50876C (en) Process for the preparation of therapeutically active N-substituted imidazoles and their salts.
FI45968C (en) Analogous process for the production of racemic or optically active, pharmacodynamically active 5-phenyl-6,7-benzomorphans.
DK124081B (en) Analogous process for the preparation of racemic or optically active piperazine derivatives or acid addition salts thereof.
FI51704C (en) Process for the preparation of therapeutically active 4-methoxy-5,12-dioxo-6,9,11-trihydroxy-7- (0-2,3,6-tridesoxy-3-amino-1-L-lyxohexosyl) -7 -ac ethylhexahydronaphthacene derivatives and their salts.
FI49512C (en) Process for the preparation of novel therapeutically active s-triazinyl-piperazine derivatives.
FI47365C (en) Process for the preparation of new therapeutically active indolder t.
DK119877B (en) Analogous process for the preparation of therapeutically active carboxylic acids or pharmaceutically acceptable salts thereof.
DK120597B (en) Analogous process for the preparation of racemic or optically active 10b-substituted hexahydro- or octahydrophenanthridine derivatives or salts thereof.
FI48922C (en) Process for the preparation of pharmaceutically active novel, both racemic and optically active substituted 1-phenoxy-2-hydroxy-3-tert-butyl aminopropanes and these salts.
DK119009B (en) Analogous process for the preparation of optically active or racemic 5,9-diethyl-2'-hydroxy-2-substituted-6,7-benzomorphan compounds or acid addition salts thereof.
DK129235B (en) Process for the preparation of racemic or optically active quinoline derivatives or acid addition salts thereof.
FI52861C (en) Process for the preparation of antimicrobially active 2- (5-nitro-2-imidazolyl) -benzimidazoles.
DK138988B (en) Analogous process for the preparation of racemic or optically active morphinan derivatives.
FI51182C (en) Process for the preparation of novel blood glucose lowering 2-benzenesulfonate midopyrimidine derivatives.
DK123102B (en) Analogous process for the preparation of racemic or optically active benzo [b] thiopheneacetic acid compounds or carboxylate salts thereof.
FI48576C (en) Process for the preparation of therapeutically active alpha-fluoromalic acid derivatives.
DK121513B (en) Analogous process for the preparation of racemic or optically active N-substituted noratropinium salts.
FI45045C (en) Process for the preparation of novel therapeutically active 5-nitro-2-furyl-isoxazole derivatives.